110 related articles for article (PubMed ID: 23774208)
1. DDB2: a novel regulator of NF-κB and breast tumor invasion.
Ennen M; Klotz R; Touche N; Pinel S; Barbieux C; Besancenot V; Brunner E; Thiebaut D; Jung AC; Ledrappier S; Domenjoud L; Abecassis J; Plénat F; Grandemange S; Becuwe P
Cancer Res; 2013 Aug; 73(16):5040-52. PubMed ID: 23774208
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells.
Ennen M; Minig V; Grandemange S; Touche N; Merlin JL; Besancenot V; Brunner E; Domenjoud L; Becuwe P
Free Radic Biol Med; 2011 Jun; 50(12):1771-9. PubMed ID: 21419216
[TBL] [Abstract][Full Text] [Related]
3. Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.
Song ZB; Ni JS; Wu P; Bao YL; Liu T; Li M; Fan C; Zhang WJ; Sun LG; Huang YX; Li YX
Cell Death Dis; 2015 Mar; 6(3):e1703. PubMed ID: 25811800
[TBL] [Abstract][Full Text] [Related]
4. bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells.
Ricca A; Biroccio A; Del Bufalo D; Mackay AR; Santoni A; Cippitelli M
Int J Cancer; 2000 Apr; 86(2):188-96. PubMed ID: 10738245
[TBL] [Abstract][Full Text] [Related]
5. Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation.
Kang H; Jang SW; Pak JH; Shim S
Mol Cell Biochem; 2015 May; 403(1-2):85-94. PubMed ID: 25670016
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.
Bendinelli P; Matteucci E; Maroni P; Desiderio MA
Mol Cancer Res; 2009 Aug; 7(8):1328-41. PubMed ID: 19671685
[TBL] [Abstract][Full Text] [Related]
7. Tianeptine sodium salt suppresses TNF-α-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-κB pathway.
Jayasooriya RG; Dilshara MG; Choi YH; Moon SK; Kim WJ; Kim GY
Environ Toxicol Pharmacol; 2014 Sep; 38(2):502-9. PubMed ID: 25168152
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
Sliva D; English D; Lyons D; Lloyd FP
Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.
Ray A; Dhar S; Ray BK
Mol Cancer Res; 2010 Sep; 8(9):1261-70. PubMed ID: 20688878
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid induces nuclear factor kappaB activation and matrix metalloproteinase-9 expression and enhances basement membrane invasivity of differentiation-resistant human SK-N-BE 9N neuroblastoma Cells.
Farina AR; Masciulli MP; Tacconelli A; Cappabianca L; De Santis G; Gulino A; Mackay AR
Cell Growth Differ; 2002 Aug; 13(8):343-54. PubMed ID: 12193473
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway.
Shao N; Lu Z; Zhang Y; Wang M; Li W; Hu Z; Wang S; Lin Y
Cancer Lett; 2015 Aug; 364(2):165-72. PubMed ID: 25979232
[TBL] [Abstract][Full Text] [Related]
13. Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.
Chao CY; Lii CK; Hsu YT; Lu CY; Liu KL; Li CC; Chen HW
Carcinogenesis; 2013 Aug; 34(8):1843-51. PubMed ID: 23615401
[TBL] [Abstract][Full Text] [Related]
14. DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells.
Barbieux C; Bacharouche J; Soussen C; Hupont S; Razafitianamaharavo A; Klotz R; Pannequin R; Brie D; Bécuwe P; Francius G; Grandemange S
Nanoscale; 2016 Mar; 8(9):5268-79. PubMed ID: 26879405
[TBL] [Abstract][Full Text] [Related]
15. Golgi tethering factor golgin-97 suppresses breast cancer cell invasiveness by modulating NF-κB activity.
Hsu RM; Zhong CY; Wang CL; Liao WC; Yang C; Lin SY; Lin JW; Cheng HY; Li PY; Yu CJ
Cell Commun Signal; 2018 Apr; 16(1):19. PubMed ID: 29703230
[TBL] [Abstract][Full Text] [Related]
16. Osteoblasts-derived TGF-beta1 enhance motility and integrin upregulation through Akt, ERK, and NF-kappaB-dependent pathway in human breast cancer cells.
Wei YY; Chen YJ; Hsiao YC; Huang YC; Lai TH; Tang CH
Mol Carcinog; 2008 Jul; 47(7):526-37. PubMed ID: 18161870
[TBL] [Abstract][Full Text] [Related]
17. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression.
Ling H; Zhang Y; Ng KY; Chew EH
Breast Cancer Res Treat; 2011 Apr; 126(3):609-20. PubMed ID: 20521099
[TBL] [Abstract][Full Text] [Related]
18. Piceatannol suppresses breast cancer cell invasion through the inhibition of MMP-9: involvement of PI3K/AKT and NF-κB pathways.
Ko HS; Lee HJ; Kim SH; Lee EO
J Agric Food Chem; 2012 Apr; 60(16):4083-9. PubMed ID: 22480333
[TBL] [Abstract][Full Text] [Related]
19. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity.
Cicek M; Fukuyama R; Welch DR; Sizemore N; Casey G
Cancer Res; 2005 May; 65(9):3586-95. PubMed ID: 15867352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
